Suchergebnisse - (Subject:"antiviral")

PubPharm (9)

1

Severe acute hepatitis B in a treatment-naïve patient with antiviral drug resistant mutations in the polymerase gene

enthalten in: Journal of medical virology | 2013

von Morando, F. | Rosi, S. | Fasolato, S. | +4

2

Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1

enthalten in: Journal of medical virology | 2012

von Lascaux, A. | Caumes, E. | Deback, C. | +4

3

Molecular characterization of hepatitis B virus and a 9-year clinical profile in a patient infected with genotype I

enthalten in: Journal of medical virology | 2010

von Osiowy, C. | Kaita, K. | Solar, K. | +1

4

Dynamic changes of HBV quasispecies and deletion patterns in a chronic hepatitis B patient

enthalten in: Journal of medical virology | 2009

von Ji, F. | Zhou, L. | Ma, S. | +3

5

Susceptibility of hepatitis B virus to lamivudine restored by resistance to adefovir

enthalten in: Journal of medical virology | 2009

von Zaaijer, H. | Takkenberg, R. | Weegink, C. | +5

6

Successful treatment of an entecavir-resistant hepatitis B virus variant

enthalten in: Journal of medical virology | 2007

von Yatsuji, H. | Hiraga, N. | Mori, N. | +11

7

Redetection of HBV lamivudine-resistant mutations in a patient under entecavir therapy, who had been treated sequentially with nucleos(t)ide analogues

enthalten in: Journal of medical virology | 2007

von Rodriguez-Frias, F. | Jardi, R. | Schaper, M. | +5

8

Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapy

enthalten in: Journal of medical virology | 2006

von Yeh, C. | Lin, W. | Hsu, C. | +3

9

Fatal liver failure with the emergence of hepatitis B surface antigen variants with multiple stop mutations after discontinuation of lamivudine therapy

enthalten in: Journal of medical virology | 2006

von Zhang, J. | Wang, X. | Huang, Y. | +5

1
[1]